Oregon 2023 Regular Session

Oregon House Bill HB2642

Introduced
1/9/23  
Refer
1/13/23  

Caption

Relating to prescription drug monitoring; prescribing an effective date.

Impact

The impact of HB2642 is significant as it introduces a requirement for healthcare providers to consult an established electronic system, which is intended to prevent potential abuse of prescription medications. By reinforcing this practice, the bill aims to improve monitoring of prescriptions, specifically targeting drugs that are commonly misused, thus potentially reducing the incidence of opioid overdoses in the state. The effective date of January 1, 2024, allows for the necessary preparations for stakeholders involved in the healthcare system, ensuring a smooth transition to this new requirement.

Summary

House Bill 2642 aims to enhance patient safety by mandating practitioners to query the electronic prescription monitoring system before issuing or renewing prescriptions for certain prescription drugs. This measure is part of a broader initiative to curtail prescription drug abuse and ensure that practitioners have access to important information regarding patients' prescription histories. With this bill, the Oregon Health Authority is empowered to adopt the necessary rules for its implementation, indicating a proactive stance on public health and safety.

Sentiment

The general sentiment surrounding HB2642 tends to be supportive, with health professionals and advocates alike recognizing the importance of monitoring prescriptions to combat substance abuse. However, there may be concerns regarding the implementation of this requirement, particularly regarding the additional burden it could place on practitioners, who may need to navigate new systems and processes. Overall, the bill reflects a collective recognition of the urgent need to address prescription drug misuse in a structured and regulated manner.

Contention

Notable points of contention may revolve around the balance between regulatory requirements and the practicalities faced by medical practitioners in the state. There could be debates focused on whether such regulations may inadvertently lead to delays in patient care or impose administrative challenges on healthcare professionals. Some stakeholders may argue for more flexible implementations or additional resources to ensure that healthcare providers can comply without compromising the quality of patient care.

Companion Bills

No companion bills found.

Previously Filed As

OR HB3258

Relating to prescription drug monitoring; and prescribing an effective date.

OR HB4150

Relating to prescription monitoring program; and prescribing an effective date.

OR SB716

Relating to off-label indications for prescription drugs; prescribing an effective date.

OR SB404

Relating to prescription drugs; prescribing an effective date.

OR SB192

Relating to prescription drugs; and prescribing an effective date.

OR HB3223

Relating to prescription drugs; prescribing an effective date.

OR HB2057

Relating to prescription drugs; prescribing an effective date.

OR HB2887

Relating to short-acting opioid antagonists; prescribing an effective date.

OR SB559

Relating to the prescription drug monitoring program.

OR HB2760

Relating to exemption of prescription drug sales; prescribing an effective date.

Similar Bills

No similar bills found.